CXCL12 and Miyoshi myopathy: CXCL12 induced signaling enhances MM cell motility, facilitates cytoskeletal rearrangements, and promotes transient upregulation and increased affinity of VLA-4 (α4β1) to bind its cognate ligand VCAM1, which is expressed by BM vascular endothelium (161–163).